165 related articles for article (PubMed ID: 25451689)
1. Ceramide synthases CerS4 and CerS5 are upregulated by 17β-estradiol and GPER1 via AP-1 in human breast cancer cells.
Wegner MS; Wanger RA; Oertel S; Brachtendorf S; Hartmann D; Schiffmann S; Marschalek R; Schreiber Y; Ferreirós N; Geisslinger G; Grösch S
Biochem Pharmacol; 2014 Dec; 92(4):577-89. PubMed ID: 25451689
[TBL] [Abstract][Full Text] [Related]
2. GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells.
Wegner MS; Gruber L; Schömel N; Trautmann S; Brachtendorf S; Fuhrmann D; Schreiber Y; Olesch C; Brüne B; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2019 Jul; 112():95-106. PubMed ID: 31082617
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
4. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
[TBL] [Abstract][Full Text] [Related]
5. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
Jang SW; Park WJ; Min H; Kwon TK; Baek SK; Hwang I; Kim S; Park JW
Oncol Rep; 2018 Dec; 40(6):3489-3500. PubMed ID: 30272337
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2.
Becker I; Wang-Eckhardt L; Yaghootfam A; Gieselmann V; Eckhardt M
Histochem Cell Biol; 2008 Feb; 129(2):233-41. PubMed ID: 17901973
[TBL] [Abstract][Full Text] [Related]
9. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1.
Jiang QF; Wu TT; Yang JY; Dong CR; Wang N; Liu XH; Liu ZM
J Steroid Biochem Mol Biol; 2013 Nov; 138():314-24. PubMed ID: 23907016
[TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta.
O'Neil JS; Burow ME; Green AE; McLachlan JA; Henson MC
Mol Cell Endocrinol; 2001 May; 176(1-2):67-75. PubMed ID: 11369444
[TBL] [Abstract][Full Text] [Related]
11. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.
Hartmann D; Lucks J; Fuchs S; Schiffmann S; Schreiber Y; Ferreirós N; Merkens J; Marschalek R; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2012 Apr; 44(4):620-8. PubMed ID: 22230369
[TBL] [Abstract][Full Text] [Related]
12. Modulation of ceramide synthase activity via dimerization.
Laviad EL; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2012 Jun; 287(25):21025-33. PubMed ID: 22539345
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
14. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
[TBL] [Abstract][Full Text] [Related]
15. Eleven residues determine the acyl chain specificity of ceramide synthases.
Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.
Marchiori AC; Casolari DA; Nagai MA
Braz J Med Biol Res; 2008 Jul; 41(7):579-82. PubMed ID: 18641796
[TBL] [Abstract][Full Text] [Related]
17. Ceramide synthases and ceramide levels are increased in breast cancer tissue.
Schiffmann S; Sandner J; Birod K; Wobst I; Angioni C; Ruckhäberle E; Kaufmann M; Ackermann H; Lötsch J; Schmidt H; Geisslinger G; Grösch S
Carcinogenesis; 2009 May; 30(5):745-52. PubMed ID: 19279183
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
19. Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers.
Mojakgomo R; Mbita Z; Dlamini Z
Exp Mol Pathol; 2015 Jun; 98(3):585-92. PubMed ID: 25779024
[TBL] [Abstract][Full Text] [Related]
20. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
Zhang YH; Li G; Yu J; Xu MS; Liu ZX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
